| The skeletal muscle-metabolism axis in prostate-cancer therapy. | |
| | |
MedLine Citation:
|
PMID: 23215572 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
To the Editor: Basaria and Bhasin (Sept. 6 issue)(1) report that men with prostate cancer who are receiving androgen-deprivation therapy have multiple adverse events. The authors included follistatin and irisin between the main targets of investigation to prevent and treat the metabolic side effects associated with androgen-deprivation therapy. It has been shown that exercise induces a marked increase in plasma and muscle follistatin and irisin.(2)-(4) Follistatin expression changes in both the muscle and fat of diabetic rats and can be modulated by exercise.(5) Concentrations of irisin increase significantly after exercise in both mice and humans, and irisin levels in . . . |
| | |
Authors:
|
Fabian Sanchis-Gomar |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: The New England journal of medicine Volume: 367 ISSN: 1533-4406 ISO Abbreviation: N. Engl. J. Med. Publication Date: 2012 Dec |
Date Detail:
|
Created Date: 2012-12-11 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0255562 Medline TA: N Engl J Med Country: United States |
Other Details:
|
Languages: eng Pagination: 2257-8 Citation Subset: AIM; IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: MYD88 L265P Somatic Mutation in IgM MGUS.
Next Document: There is more to life than death.